SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001683168-24-004259
Filing Date
2024-06-17
Accepted
2024-06-17 11:17:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT TO PROSPECTUS DATED MAY 17, 2024 cns_424b5.htm 424B5 374930
  Complete submission text file 0001683168-24-004259.txt   375968
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-279285 | Film No.: 241047321
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)